Gallbladder Neoplasms Clinical Trial
— CRGGCOfficial title:
Chinese Research Group of Gallbladder Cancer
The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer). - Patients with accessible electronic medical record Exclusion Criteria: - Patients with undetermined primary site of cancer. |
Country | Name | City | State |
---|---|---|---|
China | Baotou City Central Hospital | Baotou | Inner Mongolia |
China | The First Affiliated Hospital of Bengbu Medical College | Bengbu | Anhui |
China | China-Japan Union Hospital of Jilin University | Changchun | Jilin |
China | The First Bethune Hospital of Jilin University | Changchun | Jilin |
China | The Second Hospital of Jilin University | Changchun | Jilin |
China | People's Hospital of Hunan Province | Changsha | Hunan |
China | Changshu No.1 People's Hospital | Changshu | Jiangsu |
China | Heping Hospital Affiliated to Changzhi Medical College | Changzhi | Shanxi |
China | Changzhou No.2 People's Hospital | Changzhou | Jiangsu |
China | The First Hospital of Lanzhou University | Gansu | Lanzhou |
China | Sir Run Run Shaw Hospital | Hangzhou | Zhejiang |
China | The Second Affiliated Hospital of Zhejiang University School of medicine | Hangzhou | Zhejiang |
China | Zhejiang Cancer Hospital | Hangzhou | Zhejiang |
China | Harbin Medical University Cancer Hospital | Harbin | Heilongjiang |
China | The First Affiliated Hospital of Harbin Medical University | Harbin | Heilongjiang |
China | The Second Affiliated Hospital of Harbin Medical University | Harbin | Heilongjiang |
China | Anhui Provincial Hospital | Hefei | Anhui |
China | The First Affiliated Hospital of Anhui Medical University | Hefei | Anhui |
China | Huzhou Central Hospital | Huzhou | Zhejiang |
China | The First Affiliated Hospital of Kunming Medical University | Kunming | Yunnan |
China | Jiangxi Provincial People's Hospital | Nanchang | Jiangxi |
China | The First Affiliated Hospital of Nanchang University | Nanchang | Jiangxi |
China | The Second Affiliated Hospital of Nanchang University | Nanchang | Jiangxi |
China | Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School | Nanjing | Jiangsu |
China | Affiliated Hospital of Nantong University | Nantong | Jiangsu |
China | Nantong Tumor Hospital | Nantong | Jiangsu |
China | The First People's Hospital of Nantong | Nantong | Jiangsu |
China | Ningbo First Hospital | Ningbo | Zhejiang |
China | Yinzhou Hospital Affiliated to Medical School of Ningbo University | Ningbo | Zhejiang |
China | Central Hospital of Minhang District | Shanghai | Shanghai |
China | Eastern Hepatobiliary Surgery Hospital | Shanghai | Shanghai |
China | Putuo District People's Hospital of Shanghai | Shanghai | Shanghai |
China | Shanghai Fengxian District Central Hospital | Shanghai | Shanghai |
China | Shanghai General Hospital | Shanghai | Shanghai |
China | Shanghai Pudong Hospital | Shanghai | Shanghai |
China | Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | Shanghai |
China | Xinhua Hospital | Shanghai | Shanghai |
China | Zhongshan Hospital | Shanghai | Shanghai |
China | Shaoxing People's Hospital | Shaoxing | Zhejiang |
China | Shaoxing Second Hospital | Shaoxing | Zhejiang |
China | Shengjing Hospital of China Medical University | Shenyang | Liaoning |
China | The Second Affiliated Hospital of Suzhou University | Suzhou | Jiangsu |
China | The First People's Hospital of Taicang | Taicang | Jiangsu |
China | First Hospital of Shanxi Medical University | Taiyuan | Shanxi |
China | Shanxi Provincial Cancer Hospital | Taiyuan | Shanxi |
China | Tianjin Medical University Cancer Hospital | Tianjin | Tianjin |
China | The First Affiliated Hospital of Xinjiang Medical University | Ürümqi | Xinjiang |
China | The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | Zhejiang |
China | Wuxi Second People's Hospital | Wuxi | Jiangsu |
China | The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an | Shaanxi |
China | Qinghai Provincial People's Hospital | Xining | Qinghai |
China | The Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu |
China | Xuzhou Central Hospital | Xuzhou | Jiangsu |
China | Henan Cancer Hospital | Zhengzhou | Henan |
China | The Fifth Affiliated Hospital of Zhengzhou University | Zhengzhou | Henan |
Lead Sponsor | Collaborator |
---|---|
Shanghai Jiao Tong University School of Medicine | Affiliated Hospital of Nantong University, Anhui Provincial Hospital, Baotou Central Hospital, Central Hospital of Minhang District, Shanghai, Changzhi Medical College, Changzhou No.2 People's Hospital, China-Japan Union Hospital, Jilin University, Eastern Hepatobiliary Surgery Hospital, First Affiliated Hospital Bengbu Medical College, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital Xi'an Jiaotong University, Hainan People's Hospital, Harbin Medical University, Henan Cancer Hospital, Huizhou Municipal Central Hospital, Jiangxi Provincial Cancer Hospital, Jiangxi Provincial People's Hopital, LanZhou University, Ningbo No. 1 Hospital, People's Hospital of Hunan Province, Putuo District People's Hospital of Shanghai, Qilu Hospital of Shandong University, Qinghai People's Hospital, Second Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Suzhou University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Second Hospital of Jilin University, Shandong Provincial Hospital, Shanghai Fengxian District Central Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Pudong Hospital, Shanghai Zhongshan Hospital, Shanxi Provincial Cancer Hospital, Shaoxing People's Hospital, Shaoxing Second Hospital, Shengjing Hospital, Sir Run Run Shaw Hospital, Taizhou Municipal Hospital, The Affiliated Hospital of Qingdao University, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Kunming Medical College, The First Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Zhengzhou University, The First Hospital of Jilin University, The First People's Hospital of Changzhou, The First People's Hospital of Nantong, The First People's Hospital of Taicang, The Second Affiliated Hospital of Harbin Medical University, Tianjin Medical University Cancer Hospital, Tongliao City Hospital, Wuxi Second People's Hospital, Xijing Hospital, Xinghua City People's Hospital, Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Xuzhou Central Hospital, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Zhejiang Cancer Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall Survival | The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
Completed |
NCT01053390 -
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
|
Phase 3 | |
Completed |
NCT03510923 -
Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
|
||
Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06276153 -
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
|
||
Completed |
NCT06178848 -
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
|
N/A | |
Withdrawn |
NCT02174575 -
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
|
Phase 4 | |
Completed |
NCT02430662 -
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
|
N/A | |
Completed |
NCT01242605 -
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
|
Phase 1 |